Literature DB >> 11391064

Neurobiological processes in alcohol addiction.

A D Lê1, K Kiianmaa, C L Cunningham, J A Engel, M Ericson, B Söderpalm, G F Koob, A J Roberts, F Weiss, P Hyytiä, S Janhunen, J Mikkola, P Bäckström, I Ponomarev, J C Crabbe.   

Abstract

This article represents the proceedings of a symposium at the ISBRA Meeting in Yokohama, Japan. The chairs were A. D. Lê and K. Kiianmaa. The presentations were (1) Alcohol reward and aversion, by C. L. Cunningham; (2) The role of sensitization of neuronal mechanisms in ethanol self-administration, by J. A. Engel, M. Ericson, and B. Söderpalm; (3) Alcohol self-administration in dependent animals: Neurobiological mechanisms, by G. F. Koob, A. J. Roberts, and F. Weiss; (4) Stress and relapse to alcohol, by A. D. Lê; (5) Alcohol-preferring AA and alcohol-avoiding ANA rats differ in locomotor activation induced by repeated morphine injections, by P. Hyytiä, S. Janhunen, J. Mikkola, P. Bäckström, and K. Kiianmaa; and (6) Initial sensitivity and acute functional tolerance to the hypnotic effects of ethanol in mice genetically selected for mild and severe ethanol withdrawal convulsions, by I. Ponomarev and J. C. Crabbe.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11391064     DOI: 10.1111/j.1530-0277.2001.tb02389.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  10 in total

1.  Preference for ethanol in zebrafish following a single exposure.

Authors:  Priya Mathur; Michael A Berberoglu; Su Guo
Journal:  Behav Brain Res       Date:  2010-10-23       Impact factor: 3.332

Review 2.  Rat animal models for screening medications to treat alcohol use disorders.

Authors:  Richard L Bell; Sheketha R Hauser; Tiebing Liang; Youssef Sari; Antoniette Maldonado-Devincci; Zachary A Rodd
Journal:  Neuropharmacology       Date:  2017-02-16       Impact factor: 5.250

3.  What are the Patterns Between Depression, Smoking, Unhealthy Alcohol Use, and Other Substance Use Among Individuals Receiving Medical Care? A Longitudinal Study of 5479 Participants.

Authors:  Kelly V Ruggles; Yixin Fang; Janet Tate; Sherry M Mentor; Kendall J Bryant; David A Fiellin; Amy C Justice; R Scott Braithwaite
Journal:  AIDS Behav       Date:  2017-07

4.  Assessment of the Drug-Drug Interaction Potential Between Theacrine and Caffeine in Humans.

Authors:  Hui He; Dejian Ma; Laura Brooks Crone; Matthew Butawan; Bernd Meibohm; Richard J Bloomer; Charles R Yates
Journal:  J Caffeine Res       Date:  2017-09-01

5.  Craving in response to stress induction in a human laboratory paradigm predicts treatment outcome in alcohol-dependent individuals.

Authors:  Amanda E Higley; Natania A Crane; Andrea D Spadoni; Susan B Quello; Vivian Goodell; Barbara J Mason
Journal:  Psychopharmacology (Berl)       Date:  2011-05-24       Impact factor: 4.530

Review 6.  Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism.

Authors:  Emily G Lowery; Todd E Thiele
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-03       Impact factor: 4.388

Review 7.  Activators of G-protein signaling 3: a drug addiction molecular gateway.

Authors:  Michael Scott Bowers
Journal:  Behav Pharmacol       Date:  2010-09       Impact factor: 2.293

8.  MeCP2 regulates ethanol sensitivity and intake.

Authors:  Vez Repunte-Canonigo; Jihuan Chen; Celine Lefebvre; Tomoya Kawamura; Max Kreifeldt; Oan Basson; Amanda J Roberts; Pietro Paolo Sanna
Journal:  Addict Biol       Date:  2013-02-28       Impact factor: 4.280

9.  Effect of topiramate treatment on ethanol consumption in rats.

Authors:  Florence J Breslin; Bankole A Johnson; Wendy J Lynch
Journal:  Psychopharmacology (Berl)       Date:  2009-10-13       Impact factor: 4.530

10.  Protective effects of nicotine on ethanol-induced toxicity in cultured cerebellar granule cells.

Authors:  Yousef Tizabi; Mashael Al-Namaeh; Kebreten F Manaye; Robert E Taylor
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.